| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | DNHD1 MYO1A MYO1D MYO5B MYO7A MYO1H KIF1B KIF20A MYO1F DNAH6 MYO16 KLC1 | 8.25e-11 | 118 | 149 | 12 | GO:0003774 |
| GeneOntologyMolecularFunction | actin filament binding | MYO1A MYO1D MYO5B MYO7A MYO1H FHOD3 LCP1 POF1B ACTR2 FRG1 MYO1F EPS8L3 MYO16 | 1.61e-08 | 227 | 149 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNA1C FKBP15 MYO1A MYO1D MYO5B MYO7A MYO1H KIF1B CEP290 KLC2 BBS4 FHOD3 LCP1 POF1B ACTR2 KIF20A FRG1 SYNE2 MYO1F CEP70 CDK5RAP2 ABCG2 EPS8L3 MYO16 KLC1 NIN | 1.55e-07 | 1099 | 149 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 ERCC3 DDX17 MYO1A MYO1D MYO5B MYO7A ABCA13 ZGRF1 MYO1H KIF1B ZNFX1 CHD2 DDX1 KIF20A MYO1F ABCG2 ASCC3 DNAH6 | 1.65e-07 | 614 | 149 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.54e-07 | 38 | 149 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | actin binding | FKBP15 MYO1A MYO1D MYO5B MYO7A MYO1H FHOD3 LCP1 POF1B ACTR2 FRG1 SYNE2 MYO1F EPS8L3 MYO16 | 3.11e-06 | 479 | 149 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | calmodulin binding | CACNA1C CACNA1S CAMKK1 MYO1A MYO1D MYO5B MYO7A MKNK1 MYO1F CDK5RAP2 | 9.14e-06 | 230 | 149 | 10 | GO:0005516 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.40e-04 | 14 | 149 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | helicase activity | 1.86e-04 | 158 | 149 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ERCC3 DDX17 MYO5B ABCA13 KIF1B CHD2 DDX1 KIF20A ABCG2 ASCC3 DNAH6 | 4.85e-04 | 441 | 149 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 5.75e-04 | 137 | 149 | 6 | GO:0019783 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | ADCY10 CACNA1C MYO1A MYO1D MYO5B MYO7A DSP MYO1H AKAP9 SYNE2 | 1.50e-07 | 153 | 147 | 10 | GO:0030048 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT26 MAGEL2 MYO1A RIPK1 MYO1D MYO5B MYO7A DSP MYO1H BBS4 FHOD3 LCP1 CCDC57 POF1B ACTR2 AKAP9 PDE4DIP MYO1F CDK5RAP2 NIN | 1.55e-05 | 957 | 147 | 20 | GO:0097435 |
| GeneOntologyBiologicalProcess | cilium assembly | DNHD1 TTC39C CEP290 BBS4 ODF2 CCDC57 ACTR2 EXOC5 WDR11 SYNE2 CEP70 HYDIN CFAP46 | 1.82e-05 | 444 | 147 | 13 | GO:0060271 |
| GeneOntologyBiologicalProcess | microtubule-based process | ADCY10 DNHD1 KIF1B CEP290 KLC2 BBS4 ODF2 CCDC57 ACTR2 KIF20A AKAP9 GCC2 SYNE2 PDE4DIP CEP70 CDK5RAP2 DNAH6 HYDIN KLC1 CFAP46 NIN | 2.01e-05 | 1058 | 147 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DNHD1 MYO1A TTC39C CEP290 BBS4 ODF2 CCDC57 ACTR2 EXOC5 WDR11 SYNE2 CEP70 EPS8L3 HYDIN CFAP46 PLCE1 | 2.42e-05 | 670 | 147 | 16 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | DNHD1 MYO1A TTC39C CEP290 BBS4 ODF2 CCDC57 ACTR2 EXOC5 WDR11 SYNE2 CEP70 EPS8L3 HYDIN CFAP46 PLCE1 | 3.16e-05 | 685 | 147 | 16 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium organization | DNHD1 TTC39C CEP290 BBS4 ODF2 CCDC57 ACTR2 EXOC5 WDR11 SYNE2 CEP70 HYDIN CFAP46 | 3.76e-05 | 476 | 147 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | vesicle tethering | 7.62e-05 | 32 | 147 | 4 | GO:0099022 | |
| GeneOntologyBiologicalProcess | cytosolic transport | 1.02e-04 | 150 | 147 | 7 | GO:0016482 | |
| GeneOntologyBiologicalProcess | organelle localization | TRAPPC11 IL13RA2 MYO1A MYO5B MYO7A KIF1B CEP290 KLC2 ACTR2 EXOC5 AKAP9 WDR11 SYNE2 TRAPPC10 CDK5RAP2 | 1.54e-04 | 703 | 147 | 15 | GO:0051640 |
| GeneOntologyCellularComponent | myosin complex | 1.85e-07 | 59 | 147 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | pericentriolar material | 4.21e-05 | 28 | 147 | 4 | GO:0000242 | |
| GeneOntologyCellularComponent | cilium | ADCY10 DNHD1 CACNA1F MYO7A ABHD2 CEP290 KLC2 BBS4 ODF2 AKAP9 WDR11 PIP4K2A DNAH6 HYDIN ANKS3 KLC1 CFAP46 NIN | 6.16e-05 | 898 | 147 | 18 | GO:0005929 |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1C CACNA1S KRT26 MYO1A DSP KIF1B KLC2 FHOD3 ODF2 LCP1 CCDC57 POF1B KIF20A FRG1 SYNE2 PDE4DIP MYO1F CDK5RAP2 DNAH6 KLC1 NIN | 7.94e-05 | 1179 | 147 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1C CACNA1S KRT26 MYO1A DSP KIF1B KLC2 FHOD3 ODF2 LCP1 CCDC57 POF1B KIF20A FRG1 SYNE2 PDE4DIP MYO1F CDK5RAP2 DNAH6 KLC1 NIN | 8.74e-05 | 1187 | 147 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | actin cytoskeleton | FKBP15 MYO1A MYO1D MYO5B MYO7A MYO1H FHOD3 DGKH LCP1 POF1B ACTR2 MYO1F MYO16 | 2.21e-04 | 576 | 147 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | cell cortex | MYO1A MYO1D MYO5B MYO7A FRMPD1 ACTR2 EXOC5 HMCN2 PDE4DIP MYO1F | 3.03e-04 | 371 | 147 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | kinesin complex | 3.89e-04 | 49 | 147 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT26 MYO1A DSP KIF1B KLC2 ODF2 LCP1 CCDC57 POF1B KIF20A PDE4DIP MYO1F CDK5RAP2 DNAH6 KLC1 NIN | 6.02e-04 | 899 | 147 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule associated complex | 9.84e-04 | 161 | 147 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 1.13e-03 | 111 | 147 | 5 | GO:0001750 | |
| Domain | P-loop_NTPase | ADCY10 DNHD1 ERCC3 DDX17 MYO1A MYO1D MYO5B MYO7A ABCA13 ZGRF1 KIF1B ZNFX1 CHD2 DDX1 KIF20A TRANK1 GNA14 MYO1F ABCG2 ASCC3 DNAH6 HYDIN MYO16 CARD14 NLRP13 | 1.09e-08 | 848 | 147 | 25 | IPR027417 |
| Domain | Myosin_head_motor_dom | 4.81e-07 | 38 | 147 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.81e-07 | 38 | 147 | 6 | PS51456 | |
| Domain | Myosin_head | 4.81e-07 | 38 | 147 | 6 | PF00063 | |
| Domain | MYSc | 4.81e-07 | 38 | 147 | 6 | SM00242 | |
| Domain | VDCC_L_a1su | 1.90e-06 | 4 | 147 | 3 | IPR005446 | |
| Domain | - | ADCY10 DNHD1 ERCC3 DDX17 MYO7A ABCA13 ZGRF1 ZNFX1 CHD2 DDX1 TRANK1 GNA14 MYO1F ABCG2 ASCC3 DNAH6 HYDIN CARD14 NLRP13 | 6.44e-06 | 746 | 147 | 19 | 3.40.50.300 |
| Domain | Rab5-bind | 9.39e-06 | 6 | 147 | 3 | PF09311 | |
| Domain | Rabaptin_Rab5-bd_dom | 9.39e-06 | 6 | 147 | 3 | IPR015390 | |
| Domain | TPR-like_helical_dom | ADCY10 ATR TTC16 TTC39C KLC2 BBS4 TRANK1 TRAPPC10 KLC1 CFAP46 | 1.61e-05 | 233 | 147 | 10 | IPR011990 |
| Domain | Ca_chan_IQ | 1.63e-05 | 7 | 147 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 1.63e-05 | 7 | 147 | 3 | PF08763 | |
| Domain | VDCC_a1su_IQ | 1.63e-05 | 7 | 147 | 3 | IPR014873 | |
| Domain | Myosin_TH1 | 1.63e-05 | 7 | 147 | 3 | PF06017 | |
| Domain | GPHH | 1.63e-05 | 7 | 147 | 3 | PF16905 | |
| Domain | GPHH_dom | 1.63e-05 | 7 | 147 | 3 | IPR031649 | |
| Domain | Myosin_TH1 | 1.63e-05 | 7 | 147 | 3 | IPR010926 | |
| Domain | TH1 | 1.63e-05 | 7 | 147 | 3 | PS51757 | |
| Domain | - | 3.90e-05 | 207 | 147 | 9 | 1.25.40.10 | |
| Domain | IQ | 4.29e-05 | 81 | 147 | 6 | SM00015 | |
| Domain | TPR_REGION | 4.93e-05 | 165 | 147 | 8 | PS50293 | |
| Domain | TPR | 4.93e-05 | 165 | 147 | 8 | PS50005 | |
| Domain | VDCCAlpha1 | 5.50e-05 | 10 | 147 | 3 | IPR002077 | |
| Domain | IQ_motif_EF-hand-BS | 7.76e-05 | 90 | 147 | 6 | IPR000048 | |
| Domain | IQ | 9.32e-05 | 93 | 147 | 6 | PS50096 | |
| Domain | Cnn_1N | 1.84e-04 | 3 | 147 | 2 | IPR012943 | |
| Domain | CAC1F_C | 1.84e-04 | 3 | 147 | 2 | IPR031688 | |
| Domain | KINESIN_LIGHT | 1.84e-04 | 3 | 147 | 2 | PS01160 | |
| Domain | CAC1F_C | 1.84e-04 | 3 | 147 | 2 | PF16885 | |
| Domain | Kinesin_light_repeat | 1.84e-04 | 3 | 147 | 2 | IPR015792 | |
| Domain | Cnn_1N | 1.84e-04 | 3 | 147 | 2 | PF07989 | |
| Domain | IQ | 2.42e-04 | 71 | 147 | 5 | PF00612 | |
| Domain | Kinesin_light | 3.65e-04 | 4 | 147 | 2 | IPR002151 | |
| Domain | TPR_repeat | 6.48e-04 | 133 | 147 | 6 | IPR019734 | |
| Domain | TPR_10 | 9.04e-04 | 6 | 147 | 2 | PF13374 | |
| Domain | TPR-contain_dom | 1.21e-03 | 150 | 147 | 6 | IPR013026 | |
| Domain | Helicase_C | 1.58e-03 | 107 | 147 | 5 | PF00271 | |
| Domain | HELICc | 1.58e-03 | 107 | 147 | 5 | SM00490 | |
| Domain | Helicase_C | 1.64e-03 | 108 | 147 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 1.71e-03 | 109 | 147 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.71e-03 | 109 | 147 | 5 | PS51192 | |
| Domain | DEXDc | 1.71e-03 | 109 | 147 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.78e-03 | 110 | 147 | 5 | IPR014001 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | PDS5B CEP290 HDAC8 ODF2 AKAP9 CEP70 NUP133 CDK5RAP2 SGO2 PDS5A | 5.03e-06 | 202 | 113 | 10 | MM15362 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | PDS5B CEP290 HDAC8 ODF2 AKAP9 CEP70 NUP133 CDK5RAP2 SGO2 PDS5A | 5.49e-06 | 204 | 113 | 10 | M4217 |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 9.86e-06 | 6 | 113 | 3 | M47762 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 1.35e-04 | 13 | 113 | 3 | MM15363 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 1.35e-04 | 13 | 113 | 3 | M27661 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 1.51e-04 | 34 | 113 | 4 | M42555 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 1.71e-04 | 14 | 113 | 3 | M47692 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 2.59e-04 | 71 | 113 | 5 | MM15495 | |
| Pathway | REACTOME_M_PHASE | PDS5B CEP290 HDAC8 ODF2 KIF20A AKAP9 CEP70 NUP133 CDK5RAP2 SGO2 PDS5A | 2.74e-04 | 387 | 113 | 11 | MM15364 |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 2.76e-04 | 72 | 113 | 5 | M27749 | |
| Pathway | BIOCARTA_TNFR2_PATHWAY | 3.14e-04 | 17 | 113 | 3 | M10082 | |
| Pathway | BIOCARTA_TNFR2_PATHWAY | 3.14e-04 | 17 | 113 | 3 | MM1517 | |
| Pathway | REACTOME_CELL_CYCLE | PDS5B ATR CEP290 HDAC8 TEX15 ODF2 POLA2 KIF20A AKAP9 SYNE2 CEP70 NUP133 CDK5RAP2 SGO2 PDS5A | 4.21e-04 | 694 | 113 | 15 | M543 |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 4.78e-04 | 81 | 113 | 5 | M748 | |
| Pathway | REACTOME_M_PHASE | PDS5B CEP290 HDAC8 ODF2 KIF20A AKAP9 CEP70 NUP133 CDK5RAP2 SGO2 PDS5A | 5.16e-04 | 417 | 113 | 11 | M27662 |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 5.96e-04 | 85 | 113 | 5 | MM14906 | |
| Pathway | BIOCARTA_NFKB_PATHWAY | 6.00e-04 | 21 | 113 | 3 | MM1444 | |
| Pathway | BIOCARTA_NFKB_PATHWAY | 6.00e-04 | 21 | 113 | 3 | M15285 | |
| Pathway | REACTOME_CIPROFLOXACIN_ADME | 6.27e-04 | 5 | 113 | 2 | M46440 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 6.63e-04 | 87 | 113 | 5 | M27194 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 7.74e-04 | 90 | 113 | 5 | MM14979 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 7.90e-04 | 23 | 113 | 3 | M47666 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 9.89e-04 | 95 | 113 | 5 | M6729 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.01e-03 | 25 | 113 | 3 | M47948 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 1.04e-03 | 96 | 113 | 5 | MM15207 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 1.09e-03 | 97 | 113 | 5 | M27478 | |
| Pathway | REACTOME_KINESINS | 1.11e-03 | 57 | 113 | 4 | MM15714 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 1.17e-03 | 201 | 113 | 7 | M27472 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | FKBP15 GAK ERCC3 TANK CAMKK1 ATR RIPK1 CANX CHD2 POF1B MKNK1 AKAP9 PIP4K2A PDE4DIP NUP133 CDK5RAP2 EIF3H KLC1 RAD23B | 1.78e-08 | 910 | 151 | 19 | 36736316 |
| Pubmed | 6.40e-08 | 48 | 151 | 6 | 8884266 | ||
| Pubmed | PDS5B CACNA1C DDX17 MYO1A MYO1D MYO5B DSP TTC16 CHD2 ODF2 LCP1 CCDC57 MINDY2 ACTR2 DDX1 TRIM67 UMODL1 SYNE2 PIP4K2A TOP1MT IL1R1 DNAH6 CFAP46 | 7.22e-08 | 1442 | 151 | 23 | 35575683 | |
| Pubmed | PDS5B ZNF157 CEP290 CHD2 POLA2 POF1B KIF20A FRG1 NUP133 PDS5A EIF3H ASCC3 HYDIN | 1.53e-07 | 469 | 151 | 13 | 27634302 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | FKBP15 ERCC3 RIPK1 MYO5B CEP290 POLA2 AKAP9 WDR11 GCC2 PDE4DIP UNK CDK5RAP2 EIF3H ASCC3 NIN RAD23B | 2.07e-07 | 754 | 151 | 16 | 33060197 |
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 2.37e-07 | 13 | 151 | 4 | 17920017 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 20937870 | ||
| Pubmed | 3.30e-07 | 14 | 151 | 4 | 8022818 | ||
| Pubmed | Myosin-I isozymes in neonatal rodent auditory and vestibular epithelia. | 1.59e-06 | 6 | 151 | 3 | 12486594 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 2.67e-06 | 139 | 151 | 7 | 25476789 | |
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 12900400 | ||
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 10722873 | ||
| Pubmed | 3.70e-06 | 146 | 151 | 7 | 21399614 | ||
| Pubmed | PITPNM2 GAK DDX17 MYO1D MYO5B MYO7A DSP KIF1B KLC2 ZNFX1 CNKSR2 ACTR2 NDUFS3 DDX1 PIP4K2A PDE4DIP TRAPPC10 ALB DNAH6 KLC1 | 4.18e-06 | 1431 | 151 | 20 | 37142655 | |
| Pubmed | 4.83e-06 | 152 | 151 | 7 | 34299191 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TANK MYO1D DSP KIF1B CEP290 KLC2 ODF2 LCP1 CCDC57 LRP1B WDR11 UNK KLC1 TRDMT1 NIN | 5.07e-06 | 853 | 151 | 15 | 28718761 |
| Pubmed | 6.61e-06 | 9 | 151 | 3 | 16382099 | ||
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 7.69e-06 | 303 | 151 | 9 | 25056061 | |
| Pubmed | A kinesin-1 binding motif in vaccinia virus that is widespread throughout the human genome. | 9.41e-06 | 10 | 151 | 3 | 21915095 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | GAK MYO1D DSP ZGRF1 CANX KIF1B KLC2 DDX1 RABEP1 PIP4K2A UNK NIN | 1.09e-05 | 588 | 151 | 12 | 38580884 |
| Pubmed | PDS5B FKBP15 KIF1B FRMPD1 CNKSR2 SNX19 AKAP9 GCC2 PDE4DIP PLCE1 | 1.25e-05 | 407 | 151 | 10 | 12693553 | |
| Pubmed | FKBP15 DPP4 GAK DDX17 CANX CEP290 KLC2 ACTR2 DDX1 ERGIC3 WDR11 GLG1 GCC2 NUP133 EIF3H ASCC3 KLC1 | 1.39e-05 | 1168 | 151 | 17 | 19946888 | |
| Pubmed | DUSP28 MYO1D MYO5B DSP CANX CEP290 ODF2 SNX19 AKAP9 FBXO3 WDR11 SYNE2 NUP133 CDK5RAP2 SLC12A7 NIN | 1.43e-05 | 1049 | 151 | 16 | 27880917 | |
| Pubmed | 1.60e-05 | 72 | 151 | 5 | 34882091 | ||
| Pubmed | 1.72e-05 | 12 | 151 | 3 | 16301330 | ||
| Pubmed | ABCG2 transports and transfers heme to albumin through its large extracellular loop. | 1.87e-05 | 2 | 151 | 2 | 20705604 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 25277766 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 1281468 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 31757807 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 34070827 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 22470497 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 31486084 | ||
| Pubmed | PLEKHO2 inhibits TNFα-induced cell death by suppressing RIPK1 activation. | 1.87e-05 | 2 | 151 | 2 | 34272357 | |
| Pubmed | Structural plasticity of the N-terminal capping helix of the TPR domain of kinesin light chain. | 1.87e-05 | 2 | 151 | 2 | 29036226 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 35986423 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 7635187 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CACNA1F KRT26 MYO7A DSP CANX CEP290 DGKH CHD2 ICE1 NDUFS3 PDE12 PDS5A ALB | 2.12e-05 | 736 | 151 | 13 | 29676528 |
| Pubmed | DSP ZGRF1 USP24 KLC2 CHD2 ODF2 SNX19 ACTR2 EXOC5 TRANK1 CHCHD2 ZNF841 MARVELD3 ASCC3 ZNF415 CFAP46 TRDMT1 | 2.29e-05 | 1215 | 151 | 17 | 15146197 | |
| Pubmed | TRAPPC11 MYO1D RASA2 MYO7A USP24 ZNFX1 CHD2 ZFAND4 GCC2 SYNE2 CDK5RAP2 FER1L5 | 2.42e-05 | 638 | 151 | 12 | 31182584 | |
| Pubmed | 2.67e-05 | 272 | 151 | 8 | 31010829 | ||
| Pubmed | FKBP15 CAMKK1 KIF1B KLC2 ANKRD44 AKAP9 RABEP1 TRAPPC10 UNK NIN | 2.73e-05 | 446 | 151 | 10 | 24255178 | |
| Pubmed | PDS5B MYO1D DSP CANX USP24 CHD2 LCP1 ACTR2 SYNE2 NUP133 PDS5A ASCC3 | 3.04e-05 | 653 | 151 | 12 | 22586326 | |
| Pubmed | DSP CANX NDUFB10 ACTR2 NDUFS3 EXOC5 ERGIC3 GCC2 NUP133 PDS5A EIF3H RAD23B | 3.22e-05 | 657 | 151 | 12 | 36180527 | |
| Pubmed | 3.35e-05 | 457 | 151 | 10 | 22190034 | ||
| Pubmed | 3.51e-05 | 15 | 151 | 3 | 20188150 | ||
| Pubmed | C2cd3 is critical for centriolar distal appendage assembly and ciliary vesicle docking in mammals. | 3.51e-05 | 15 | 151 | 3 | 24469809 | |
| Pubmed | 3.51e-05 | 15 | 151 | 3 | 24453333 | ||
| Pubmed | PDS5B ERCC3 POLA2 NDUFS3 INTS10 EXOC5 PDE12 WDR11 GLG1 NUP133 PDS5A | 3.61e-05 | 560 | 151 | 11 | 35241646 | |
| Pubmed | 3.72e-05 | 285 | 151 | 8 | 32838362 | ||
| Pubmed | 3.82e-05 | 142 | 151 | 6 | 30217970 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 4.16e-05 | 212 | 151 | 7 | 33853758 | |
| Pubmed | 4.31e-05 | 16 | 151 | 3 | 20301772 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 5.09e-05 | 298 | 151 | 8 | 32353859 | |
| Pubmed | Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels. | 5.60e-05 | 3 | 151 | 2 | 9668070 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 17767505 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 11206130 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 2173707 | ||
| Pubmed | mRNA for cardiac calcium channel is expressed during development of skeletal muscle. | 5.60e-05 | 3 | 151 | 2 | 8381753 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 28343969 | ||
| Pubmed | Molecular Pathway of Microtubule Organization at the Golgi Apparatus. | 5.60e-05 | 3 | 151 | 2 | 27666745 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 19574459 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 29054927 | ||
| Pubmed | Trichoplein controls microtubule anchoring at the centrosome by binding to Odf2 and ninein. | 5.60e-05 | 3 | 151 | 2 | 21325031 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 17289261 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 28592488 | ||
| Pubmed | Pds5B is required for cohesion establishment and Aurora B accumulation at centromeres. | 5.60e-05 | 3 | 151 | 2 | 24141881 | |
| Pubmed | Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity. | 5.60e-05 | 3 | 151 | 2 | 33460648 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 33316896 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | FKBP15 DDX17 MYO5B MYO7A KIF1B CEP290 BBS4 DDX1 ZNF836 EXOC5 RABEP1 GCC2 NUP133 TRAPPC10 CHCHD2 ANKS3 KLC1 | 6.47e-05 | 1321 | 151 | 17 | 27173435 |
| Pubmed | DSP KIF1B CHD2 AKAP9 RABEP1 SYNE2 PDE4DIP NUP133 CDK5RAP2 PLCE1 | 6.75e-05 | 497 | 151 | 10 | 23414517 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PDS5B CACNA1C MYO7A KLC2 CHD2 LCP1 CCDC57 TRANK1 ASCC3 HYDIN | 6.75e-05 | 497 | 151 | 10 | 36774506 |
| Pubmed | 7.39e-05 | 19 | 151 | 3 | 15529118 | ||
| Pubmed | 8.18e-05 | 101 | 151 | 5 | 26949739 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PITPNM2 CACNA1C RASA2 ABHD2 KIF1B FRMPD1 HDAC8 DGKH CHD2 CCDC57 NDUFS3 ANKRD44 WDR11 RABEP1 GCC2 ZFHX3 ZMAT1 ADGRD1 | 8.65e-05 | 1489 | 151 | 18 | 28611215 |
| Pubmed | 9.44e-05 | 418 | 151 | 9 | 34709266 | ||
| Pubmed | Characterization of mitochondrial FOXRED1 in the assembly of respiratory chain complex I. | 1.01e-04 | 21 | 151 | 3 | 25678554 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.04e-04 | 170 | 151 | 6 | 23314748 | |
| Pubmed | The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. | 1.05e-04 | 56 | 151 | 4 | 11076968 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PDS5B MYO7A HDAC8 USP24 KLC2 CCDC57 NDUFS3 TRIM66 AKAP9 GLG1 TRAPPC10 UNK CDK5RAP2 SGO2 EIF3H ADGRD1 | 1.06e-04 | 1242 | 151 | 16 | 30973865 |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 1.07e-04 | 171 | 151 | 6 | 20201926 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 19861499 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 18317468 | ||
| Pubmed | Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. | 1.12e-04 | 4 | 151 | 2 | 23602765 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 32285610 | ||
| Pubmed | Differential localization and dynamics of class I myosins in the enterocyte microvillus. | 1.12e-04 | 4 | 151 | 2 | 20089841 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 10734143 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 19625297 | ||
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 29217591 | ||
| Pubmed | Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein. | 1.12e-04 | 4 | 151 | 2 | 11106729 | |
| Pubmed | 1.12e-04 | 4 | 151 | 2 | 18772192 | ||
| Pubmed | The SUN2-nesprin-2 LINC complex and KIF20A function in the Golgi dispersal. | 1.12e-04 | 4 | 151 | 2 | 33686165 | |
| Pubmed | Advillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome. | 1.12e-04 | 4 | 151 | 2 | 29058690 | |
| Pubmed | The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. | 1.13e-04 | 57 | 151 | 4 | 16462731 | |
| Pubmed | Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. | 1.21e-04 | 58 | 151 | 4 | 12852856 | |
| Pubmed | ERCC3 CEP290 ODF2 LCP1 KIF20A FRG1 PIP4K2A SGO2 ALB NIN RAD23B | 1.27e-04 | 645 | 151 | 11 | 25281560 | |
| Pubmed | 1.27e-04 | 340 | 151 | 8 | 24332808 | ||
| Pubmed | 1.29e-04 | 177 | 151 | 6 | 26206133 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYO1A CNKSR2 ICE1 POLA2 PDE12 FBXO3 GCC2 FRG1 ALB TNFAIP3 EIF3H ASCC3 NIN RAD23B | 1.31e-04 | 1005 | 151 | 14 | 19615732 |
| Pubmed | 1.32e-04 | 255 | 151 | 7 | 15324660 | ||
| Pubmed | 1.47e-04 | 61 | 151 | 4 | 7790358 | ||
| Interaction | PCM1 interactions | MAGEL2 DSP KIF1B CEP290 BBS4 ODF2 CCDC57 ACTR2 KIF20A TRIM67 AKAP9 GCC2 CDK5RAP2 KLC1 NIN | 8.22e-07 | 434 | 149 | 15 | int:PCM1 |
| Interaction | CALM1 interactions | CACNA1C GAK CAMKK1 MYO1D MYO5B MYO7A KIF1B CEP290 ACTR2 KIF20A TRIM67 AKAP9 SYNE2 PDE4DIP UNK CDK5RAP2 RAD23B | 4.00e-06 | 626 | 149 | 17 | int:CALM1 |
| Interaction | EXOC4 interactions | 4.29e-06 | 213 | 149 | 10 | int:EXOC4 | |
| Interaction | HERC2 interactions | GAK TANK RIPK1 CEP290 FHOD3 LCP1 DDX1 KIF20A TRIM67 AKAP9 RABEP1 GCC2 SYNE2 EIF3H NIN | 5.03e-06 | 503 | 149 | 15 | int:HERC2 |
| Interaction | OFD1 interactions | TANK DSP CEP290 KLC2 BBS4 ICE1 ODF2 CCDC57 RABEP1 CDK5RAP2 KLC1 NIN | 1.08e-05 | 347 | 149 | 12 | int:OFD1 |
| Interaction | C1orf87 interactions | 1.56e-05 | 21 | 149 | 4 | int:C1orf87 | |
| Interaction | CEP170 interactions | CEP290 ODF2 ACTR2 KIF20A TRIM66 TRIM67 AKAP9 SYNE2 PDE4DIP ASCC3 NIN | 2.54e-05 | 318 | 149 | 11 | int:CEP170 |
| Interaction | KIF20A interactions | PDS5B DDX17 MYO1A MYO1D DSP CHD2 NDUFB10 NDUFS3 DDX1 KIF20A TRIM67 GNA14 RABEP1 SYNE2 MYO1F NUP133 CDK5RAP2 ABCG2 ALB GPNMB TOP1MT | 3.19e-05 | 1052 | 149 | 21 | int:KIF20A |
| GeneFamily | Myosins, class I | 9.58e-08 | 8 | 112 | 4 | 1097 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.32e-06 | 115 | 112 | 7 | 769 | |
| GeneFamily | DNA helicases | 1.48e-04 | 17 | 112 | 3 | 1167 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.42e-04 | 26 | 112 | 3 | 253 | |
| GeneFamily | UPF1 like RNA helicases | 2.02e-03 | 11 | 112 | 2 | 1169 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PDS5B DDX17 TANK ATR RASA2 MYO7A TTC39C USP24 ZNFX1 CHD2 ICE1 GMIP LCP1 ACTR2 ANKRD44 TRANK1 AKAP9 PLEKHO2 GLG1 PIP4K2A PDE4DIP MYO1F TRAPPC10 PDS5A TNFAIP3 EIF3H ASCC3 KLC1 NIN | 7.09e-09 | 1492 | 151 | 29 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B DDX17 TANK ATR USP24 AKAP9 GCC2 SYNE2 PIP4K2A NUP133 PDS5A ZFHX3 ASCC3 IL1R1 KLC1 PLCE1 RAD23B | 9.49e-06 | 856 | 151 | 17 | M4500 |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP | 2.11e-05 | 199 | 151 | 8 | M8609 | |
| Coexpression | GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 2.18e-05 | 200 | 151 | 8 | M310 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | CACNA1C MAGEL2 ZNF157 CEP290 FHOD3 CHD2 CNKSR2 ODF2 HMCN2 AKAP9 GCC2 CEP70 SGO2 | 3.65e-05 | 492 | 146 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.49e-05 | 186 | 146 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.01e-05 | 311 | 146 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 2.90e-08 | 200 | 151 | 9 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 8.12e-08 | 161 | 151 | 8 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 173 | 151 | 8 | fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 151 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 151 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 184 | 151 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 3.53e-07 | 195 | 151 | 8 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.53e-07 | 195 | 151 | 8 | 662b50a2aa97373bf343b88caace9717049c722a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-06 | 170 | 151 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.88e-06 | 181 | 151 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 3.57e-06 | 187 | 151 | 7 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 3.96e-06 | 190 | 151 | 7 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.96e-06 | 190 | 151 | 7 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 3.96e-06 | 190 | 151 | 7 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.39e-06 | 193 | 151 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.70e-06 | 195 | 151 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.02e-06 | 197 | 151 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.02e-06 | 197 | 151 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.02e-06 | 197 | 151 | 7 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.19e-06 | 198 | 151 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.61e-05 | 157 | 151 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.72e-05 | 94 | 151 | 5 | c73e99890431750b74f984de5c82e33533ab708b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.72e-05 | 94 | 151 | 5 | 1bda61101f45f5c4a68453087b880fdc6d9acfca | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.72e-05 | 94 | 151 | 5 | 9664f74bc0168c92fb8a68cad628323c476f6103 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 162 | 151 | 6 | 71d7849108a1b59beff40e46000172c45a2f5439 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-05 | 162 | 151 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 1.99e-05 | 163 | 151 | 6 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 170 | 151 | 6 | 059f7ae615342ea19f43b0a405cd7272251a78a9 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-05 | 171 | 151 | 6 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 2.61e-05 | 171 | 151 | 6 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 172 | 151 | 6 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-05 | 174 | 151 | 6 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 2.87e-05 | 174 | 151 | 6 | 51be6f29308c01593978cbee92114151a5916c9c | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 2.97e-05 | 175 | 151 | 6 | b4e4b66e89f79999768a6192c8404cb2465f920b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-05 | 181 | 151 | 6 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 3.58e-05 | 181 | 151 | 6 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.70e-05 | 182 | 151 | 6 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.70e-05 | 182 | 151 | 6 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.81e-05 | 183 | 151 | 6 | ba7753e9fe2a6a87c5264f299ac97da2ddbda178 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.81e-05 | 183 | 151 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 3.81e-05 | 183 | 151 | 6 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-05 | 183 | 151 | 6 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.81e-05 | 183 | 151 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.81e-05 | 183 | 151 | 6 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 4.05e-05 | 185 | 151 | 6 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.17e-05 | 186 | 151 | 6 | bbb8edea8d8bdc1a469faec1563e40b1f62d7f3d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.17e-05 | 186 | 151 | 6 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-05 | 186 | 151 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.43e-05 | 188 | 151 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 188 | 151 | 6 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | ILEUM-inflamed-(1)_Cytotoxic_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.43e-05 | 188 | 151 | 6 | d26894d1066a70e4b32ae41fff1c4718f2591ba9 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-05 | 189 | 151 | 6 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.56e-05 | 189 | 151 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 189 | 151 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.56e-05 | 189 | 151 | 6 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.56e-05 | 189 | 151 | 6 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.70e-05 | 190 | 151 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.70e-05 | 190 | 151 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-05 | 190 | 151 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.70e-05 | 190 | 151 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-05 | 190 | 151 | 6 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 191 | 151 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 191 | 151 | 6 | d9506b88d806aadd4c2b9bf86fe994c47799e7f6 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 4.84e-05 | 191 | 151 | 6 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 191 | 151 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 191 | 151 | 6 | b42c54308abe1241cc38ddce96b9d38d07983891 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 191 | 151 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 191 | 151 | 6 | 9aabbc65430e2233b8f2d3fff9face7807b88b48 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 191 | 151 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.98e-05 | 192 | 151 | 6 | 12f7ea575da5d650c740e6060f5dab0478e563dd | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.98e-05 | 192 | 151 | 6 | c1e2a7df7809696c482442665af5c6bb2f0e5bea | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.12e-05 | 193 | 151 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-05 | 193 | 151 | 6 | 12f1333f11e6c262954ad7912d8fd2962ab06d25 | |
| ToppCell | ILEUM-inflamed-(1)_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.27e-05 | 194 | 151 | 6 | cf22bd6afe51c42cb151c37a8b65c98649dae1a4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 194 | 151 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.27e-05 | 194 | 151 | 6 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 194 | 151 | 6 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 194 | 151 | 6 | 633fe72cc8a489abde12428e326478409ca03263 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 194 | 151 | 6 | 87a86df0b542f287b0b20f4a4b1a37002271671d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-05 | 194 | 151 | 6 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 5.27e-05 | 194 | 151 | 6 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.27e-05 | 194 | 151 | 6 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-2|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.35e-05 | 119 | 151 | 5 | d21877baa088440a1e1902bbeb667b977475437a | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 5.43e-05 | 195 | 151 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 5.43e-05 | 195 | 151 | 6 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.43e-05 | 195 | 151 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-05 | 195 | 151 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.43e-05 | 195 | 151 | 6 | 9b7157b5e4b81bc35b0e6d9b954279160ea57324 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 5.43e-05 | 195 | 151 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 5.58e-05 | 196 | 151 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.58e-05 | 196 | 151 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.58e-05 | 196 | 151 | 6 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | (2)_NK/T-(220)_CD8+_Cytotoxic_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 5.58e-05 | 196 | 151 | 6 | d123361c32bcd2329200f0316bc5b54bb494e92d | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.74e-05 | 197 | 151 | 6 | 5abe983f9750085ec7b57bcb8c36bdfe78a6ee4c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-05 | 197 | 151 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-05 | 197 | 151 | 6 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | mild-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.74e-05 | 197 | 151 | 6 | 8b0e4012e25641c3bcd3e9911031e43d9dbbff21 | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.74e-05 | 197 | 151 | 6 | 8752c0f37979aa7bf2e8aee6990fb6307a6666b7 | |
| ToppCell | (220)_CD8+_Cytotoxic_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 5.91e-05 | 198 | 151 | 6 | 2af389b8ea5767ba56fe64d719afe5be3f9a43ec | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.07e-05 | 199 | 151 | 6 | bc93e5c36ab60b66fb633c954b05d4dc09a7f152 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.46e-05 | 49 | 87 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Disease | Timothy syndrome (implicated_via_orthology) | 4.93e-07 | 4 | 148 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | frontotemporal dementia and/or amyotrophic lateral sclerosis-2 (implicated_via_orthology) | 7.47e-05 | 3 | 148 | 2 | DOID:0060214 (implicated_via_orthology) | |
| Disease | Parkinson's disease 22 (implicated_via_orthology) | 7.47e-05 | 3 | 148 | 2 | DOID:0080504 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy, Jokela type (implicated_via_orthology) | 7.47e-05 | 3 | 148 | 2 | DOID:0081356 (implicated_via_orthology) | |
| Disease | cortisol measurement | 1.32e-04 | 20 | 148 | 3 | EFO_0005843 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 2.47e-04 | 5 | 148 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | nephrotic syndrome (is_implicated_in) | 2.47e-04 | 5 | 148 | 2 | DOID:1184 (is_implicated_in) | |
| Disease | Drug habituation | 2.92e-04 | 115 | 148 | 5 | C0013170 | |
| Disease | Drug abuse | 2.92e-04 | 115 | 148 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.92e-04 | 115 | 148 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 2.92e-04 | 115 | 148 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 2.92e-04 | 115 | 148 | 5 | C0013222 | |
| Disease | Drug Dependence | 2.92e-04 | 115 | 148 | 5 | C1510472 | |
| Disease | Substance Dependence | 2.92e-04 | 115 | 148 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 2.92e-04 | 115 | 148 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.92e-04 | 115 | 148 | 5 | C0029231 | |
| Disease | Substance abuse problem | 3.04e-04 | 116 | 148 | 5 | C0740858 | |
| Disease | Unipolar Depression | 3.46e-04 | 259 | 148 | 7 | C0041696 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 3.70e-04 | 6 | 148 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement | 5.16e-04 | 7 | 148 | 2 | EFO_0004612, EFO_0600007 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 5.16e-04 | 7 | 148 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | Dermatologic disorders | 5.60e-04 | 75 | 148 | 4 | C0037274 | |
| Disease | phosphatidylcholine measurement | 5.99e-04 | 284 | 148 | 7 | EFO_0010226 | |
| Disease | pulse pressure measurement | TTC16 EFCAB13 FHOD3 CHD2 ODF2 LCP1 SNX19 TRIM66 TRANK1 PLEKHO2 PIP4K2A ZFHX3 MARVELD3 FER1L5 HYDIN PLCE1 NIN | 6.36e-04 | 1392 | 148 | 17 | EFO_0005763 |
| Disease | Sudden Cardiac Death | 6.86e-04 | 8 | 148 | 2 | C0085298 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 7.82e-04 | 36 | 148 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | MYO1H LCP1 INTS10 ERGIC3 RABEP1 GCC2 SYNE2 PDS5A ASCC3 HYDIN PLCE1 | 9.76e-04 | 713 | 148 | 11 | EFO_0005689 |
| Disease | ciliopathy (implicated_via_orthology) | 1.07e-03 | 40 | 148 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.33e-03 | 11 | 148 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Diarrhea | 1.33e-03 | 11 | 148 | 2 | C0011991 | |
| Disease | cerebrospinal fluid biomarker measurement | 1.41e-03 | 96 | 148 | 4 | EFO_0006794 | |
| Disease | melanoma | 1.62e-03 | 248 | 148 | 6 | C0025202 | |
| Disease | mean platelet volume | PITPNM2 PDS5B KIF1B LCP1 TRANK1 PLEKHO2 RABEP1 GCC2 SYNE2 LY75 SLC12A7 PLCE1 NIN | 1.94e-03 | 1020 | 148 | 13 | EFO_0004584 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.03e-03 | 106 | 148 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.24e-03 | 181 | 148 | 5 | DOID:684 (is_implicated_in) | |
| Disease | neuroticism measurement, cognitive function measurement | 2.30e-03 | 566 | 148 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.32e-03 | 110 | 148 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.49e-03 | 364 | 148 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Lymphoma, Follicular, Grade 2 | 2.51e-03 | 15 | 148 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 2.51e-03 | 15 | 148 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 2.51e-03 | 15 | 148 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 2.51e-03 | 15 | 148 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 2.51e-03 | 15 | 148 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 2.51e-03 | 15 | 148 | 2 | C0079758 | |
| Disease | behavior | 2.68e-03 | 55 | 148 | 3 | GO_0007610 | |
| Disease | myeloid white cell count | FKBP15 RASA2 CANX KIF1B DGKH GLG1 SH3D19 ZFHX3 TNFAIP3 LY75 SLC12A7 PLCE1 | 2.77e-03 | 937 | 148 | 12 | EFO_0007988 |
| Disease | Colorectal Carcinoma | ZNF560 ABCA13 CNKSR2 CPE IFNA2 AKAP9 ERGIC3 ABCG2 GPNMB EIF3H | 2.94e-03 | 702 | 148 | 10 | C0009402 |
| Disease | Hypertrophic Cardiomyopathy | 2.97e-03 | 57 | 148 | 3 | C0007194 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 3.23e-03 | 17 | 148 | 2 | C2936862 | |
| Disease | sphingomyelin 14:0 measurement | 3.23e-03 | 17 | 148 | 2 | EFO_0010390 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 3.23e-03 | 17 | 148 | 2 | OBA_2045173 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 3.28e-03 | 121 | 148 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.44e-03 | 200 | 148 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | free cholesterol in HDL measurement | 3.60e-03 | 61 | 148 | 3 | EFO_0022264 | |
| Disease | Bardet-Biedl syndrome | 3.63e-03 | 18 | 148 | 2 | cv:C0752166 | |
| Disease | Arsenic Induced Polyneuropathy | 3.77e-03 | 62 | 148 | 3 | C0751852 | |
| Disease | Arsenic Encephalopathy | 3.77e-03 | 62 | 148 | 3 | C0751851 | |
| Disease | Arsenic Poisoning | 3.77e-03 | 62 | 148 | 3 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 3.77e-03 | 62 | 148 | 3 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 3.77e-03 | 62 | 148 | 3 | C0274862 | |
| Disease | total lipids in HDL measurement | 3.94e-03 | 63 | 148 | 3 | EFO_0022307 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.01e-03 | 128 | 148 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.01e-03 | 128 | 148 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.01e-03 | 128 | 148 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.01e-03 | 128 | 148 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.01e-03 | 128 | 148 | 4 | C0007134 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 4.04e-03 | 19 | 148 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | Lymphoma, Follicular | 4.47e-03 | 20 | 148 | 2 | C0024301 | |
| Disease | dilated cardiomyopathy | 4.47e-03 | 20 | 148 | 2 | EFO_0000407 | |
| Disease | calcium measurement | 4.54e-03 | 628 | 148 | 9 | EFO_0004838 | |
| Disease | platelet component distribution width | PDS5B CACNA1C TANK LCP1 TRANK1 PLEKHO2 GCC2 PDS5A SLC12A7 TRDMT1 | 4.90e-03 | 755 | 148 | 10 | EFO_0007984 |
| Disease | haptoglobin measurement | 4.93e-03 | 21 | 148 | 2 | EFO_0004640 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QVQDVNECFYEELNA | 261 | Q5DID0 | |
| KEQLQETQGLCEYAI | 56 | Q96RK4 | |
| LEAVQEYAKFCQDNQ | 2561 | Q99996 | |
| YCQNIKEFTAQNLGK | 326 | O15372 | |
| LIKQNCELFEQLGEY | 411 | P02768 | |
| CELFEQLGEYKFQNA | 416 | P02768 | |
| DVFKGENYQKELNQC | 431 | A4D0V7 | |
| ENYQKELNQCLSLEE | 436 | A4D0V7 | |
| VNLVIGSEQDQAKCY | 206 | Q6QNK2 | |
| NIVCKYLGETQANQE | 211 | P08910 | |
| RQKCGGLQLQNEDVY | 386 | Q3SY69 | |
| QKEDANGNIVYEKNC | 106 | Q14956 | |
| NGNIVYEKNCRNEAG | 111 | Q14956 | |
| NFKCNSGYVVQDDVV | 116 | Q9UNQ0 | |
| GELACYNNAIQALQK | 1196 | Q8IYW2 | |
| GQGLVELCYNQIKYD | 4621 | Q86UQ4 | |
| QCTQKLNEANEQYVE | 831 | Q96M86 | |
| ESNIFYCFRNGKELQ | 866 | Q96PN6 | |
| YEIKQFLECAQNQGD | 116 | Q9Y6H1 | |
| QKYEEALQAQSCLQG | 151 | Q4G0W2 | |
| CYVGYNIEQEQKLAL | 221 | P61160 | |
| FNEKDLEVIQQNCYL | 496 | Q96SN8 | |
| ALQCVDYIKADGQNI | 181 | Q14627 | |
| GLVIQAYFACEKNEN | 381 | P54727 | |
| INDECYQVRQVFAQK | 911 | Q9NTI5 | |
| INDECYQVRQIFAQK | 921 | Q29RF7 | |
| EKPLYVQANNCVEAN | 681 | Q15283 | |
| CSNYEKQLQGIQIQE | 536 | Q15276 | |
| KAVNKICQQGNFQYE | 606 | Q9NVR2 | |
| LAETEGNYCNQLQQI | 331 | Q7Z3Y9 | |
| FCNEFGYQNDIDVEK | 451 | Q86VD1 | |
| RAQGEQEYQNCELDK | 1141 | O60840 | |
| EGVNIRYLDLKQNCD | 336 | Q8WUM0 | |
| VYDKEAQQGSNSCQL | 1826 | Q9NZR2 | |
| NNKLECAFGYQLKEI | 1066 | Q9UJ55 | |
| EQGEAKLNSQNLYCI | 176 | Q16288 | |
| YFELQFCERKQQLTG | 556 | Q9Y6X6 | |
| VINYCNEKLQQVFIE | 396 | Q9UBC5 | |
| QAKAQEAEALYQACV | 261 | Q9P107 | |
| QILNAQKEDAGQYTC | 2606 | Q8NDA2 | |
| DCVQLNQYKLQSEIG | 121 | Q8N5S9 | |
| CFASQNRVYNDIGKE | 66 | O60333 | |
| KIDCDNLEQYFIQQG | 516 | Q92499 | |
| EAAEGRNKNEVFYQC | 211 | Q9UK99 | |
| KLENCNYAVELGKNQ | 456 | P13796 | |
| QKELTGYNADVICLQ | 336 | Q6L8Q7 | |
| NEGCQVYGFLEVNKV | 196 | Q9Y282 | |
| QGGLTQAQYIDCFQK | 276 | Q8TE67 | |
| EGQNYQQNCIKEVEQ | 111 | O96000 | |
| EVCAQRDAYQQKLVQ | 826 | Q5T1M5 | |
| KEAYVSCQNQGADLL | 241 | O60449 | |
| KQENNILVFNAEYGN | 71 | P27487 | |
| YNGNENCIEVLLEQK | 781 | Q8N8A2 | |
| KLQQQCQFITDGYAA | 1236 | Q9BZ72 | |
| YKNLEQRVQLECDGQ | 821 | Q86XP1 | |
| ELEYCKRNLEQENQN | 421 | Q8WVV4 | |
| ALLCQNQGKAEEVEY | 331 | Q9H0B6 | |
| EEDKGNVKQCEINYV | 196 | Q14331 | |
| CDIQEKYPDLFQVNL | 691 | O14976 | |
| AVQYGNAQIIECLKE | 836 | Q92896 | |
| VYIKQCQEGAYLRND | 231 | O00471 | |
| YGIKQFLECAQNQGD | 116 | Q5T1J5 | |
| VLLGCNQEDQQEVYA | 1536 | Q13535 | |
| DQIQALQDEYDKGVN | 2931 | Q9C0G6 | |
| NIINFYEVELNECVQ | 4211 | Q4G0P3 | |
| QGCASLQQNLNEYVE | 21 | Q9Y2F5 | |
| QAQVCELQKERDQAY | 351 | Q9BXL6 | |
| IVTFQEQGEQEYKNC | 1186 | Q13936 | |
| VQNFNKDLVQDCGFE | 376 | Q8NHQ1 | |
| QGETEYKNCELDKNQ | 1071 | Q13698 | |
| EYFNCQQELASELNK | 361 | O14647 | |
| LCQDIIDYQKQIDSQ | 176 | O15078 | |
| QGCQAQEQKLFVELD | 1191 | Q5SYB0 | |
| YLQNEVFGLFQKLEN | 741 | P15924 | |
| TCLIKVGAEADQNYQ | 151 | Q2V2M9 | |
| CENLQQEKQEAILNY | 466 | Q8IWJ2 | |
| IGLDQQAEYLNQCLE | 116 | Q9P0W0 | |
| LIVQYEVNFQNGIEC | 146 | P27824 | |
| LCNEYQKGNETIVNL | 131 | P16870 | |
| AQGKLRCLQEDFVYN | 46 | Q2TAC2 | |
| NYQDGEKVAVLCKEN | 406 | Q9BXR6 | |
| DKNVDYEDLNTCLQN | 541 | Q8IY85 | |
| LYQQLNDLEACVIQG | 111 | P01563 | |
| DGEKAQQLDVQFYQL | 251 | Q96A59 | |
| QIGCLKYLQVFEEQD | 436 | Q6ZW76 | |
| LAQQVQQVADDYGKC | 256 | Q92841 | |
| LQNNGYIAKVQCAEV | 496 | P19447 | |
| IQDGIQDEKYYQICE | 231 | Q9BY41 | |
| ACDEYFIQNNVTEIQ | 351 | Q9Y666 | |
| AKFVENEPNLCYNAQ | 111 | P14778 | |
| NDFINEGQKIYIDDN | 236 | P48426 | |
| ALLCQNQGKYEEVEY | 346 | Q07866 | |
| TEAKLAECQDQLQGY | 606 | Q5BJF6 | |
| AECQDQLQGYERKNI | 611 | Q5BJF6 | |
| ETLYQCQGNKNILEL | 96 | Q9BUB5 | |
| DTLRIQYVCEQNKEN | 91 | O95837 | |
| DDIVKAVGNCSYNQL | 376 | Q8NBR6 | |
| DLLIQTIENCGFQYQ | 131 | O14717 | |
| KQTENNYLECQKGED | 446 | Q5HYK7 | |
| LDCLCQYGENVEKQQ | 3511 | Q8WXH0 | |
| SQAEAVELCYKNVNE | 6 | Q96RI9 | |
| GLQDFCQTFKLYQEQ | 1426 | A0AVI2 | |
| ECKQENQYLEGNTQL | 1386 | Q8N4C6 | |
| PENKSCNDKLQFEYN | 1606 | Q9P212 | |
| NLFPQCTKDEIQIYQ | 401 | Q0VDG4 | |
| KYVQQVQVSCFNELE | 71 | O75489 | |
| VLFLKENNQNVYGLD | 206 | Q562F6 | |
| GEQLNKAYEAFRQAC | 6 | Q92844 | |
| KLVELCVQYGQNEEG | 26 | Q14181 | |
| IFANKEPYENAICEQ | 221 | Q13546 | |
| NYGCQVTIQSEQEKQ | 321 | Q8N3C0 | |
| KGLDDCLQQYIKNFE | 21 | Q8WXI2 | |
| NKQNYKFIQGDICDS | 66 | O95455 | |
| LQQIQENGLDYEACL | 376 | Q6ZTA4 | |
| QQKNDSDCGVFVLQY | 706 | Q96HI0 | |
| VNECNVQKEGYNELK | 151 | Q8NE65 | |
| KIQTLDQNVEYNGCR | 126 | P51786 | |
| QEYNQFCVIEEASKA | 631 | Q7Z392 | |
| DEYGQFLVNCNSIQN | 301 | P20142 | |
| EGYCQKCFIEAQNQR | 671 | P21580 | |
| LCEDQNGNPYVKDLN | 331 | O95235 | |
| EAEKLQQEFGYCILD | 166 | Q969P6 | |
| AENLYQIIGIDCFQK | 551 | Q8IYM2 | |
| AQDKILYCLQEGNVE | 741 | Q92543 | |
| IGQEVAYNLLVNNCE | 106 | Q9HDD0 | |
| ALDQFLEGIYNCQKT | 661 | Q9P2E3 | |
| QLFQYEGKIYECNQV | 196 | Q96SE7 | |
| EGKIYECNQVEKSFN | 201 | Q96SE7 | |
| EKIYGCNQIERTVNN | 86 | Q6ZN19 | |
| HELQQFQAEGKIYEC | 196 | Q09FC8 | |
| LEGNIDQAQYCDRIK | 446 | Q9UPU5 | |
| CFYNVKGLEQIERDN | 1916 | Q86YA3 | |
| AQLLVYENEDDQKCV | 46 | Q8TD55 | |
| EQQEKGLYINRGDCF | 361 | Q8NEE8 | |
| LEIFQGEGKIYECNQ | 121 | Q5HY98 | |
| CVENNIENIYGDKKQ | 491 | Q9BXT5 | |
| AECQKHLGQIENYLQ | 526 | P48553 | |
| KCLGNSEDAVQYFQR | 496 | Q8N584 | |
| AKVLCGYENVNFNVL | 2486 | O15050 | |
| CENAYFQKFQLERVN | 971 | Q9BZH6 | |
| CSKQVTFLVYQEGDQ | 136 | Q86XD8 | |
| TALQQYQNPKECENF | 821 | O15016 | |
| YQNPKECENFEQGAL | 826 | O15016 | |
| EDQVGAEYLKNFKCQ | 421 | Q9C0B0 | |
| ESKVFKEGYNELNQC | 131 | Q8NEM1 | |
| ELQKFQTEGKIYECN | 151 | Q6ZNA1 | |
| RNQNGEELYDCKQCE | 206 | Q96MR9 | |
| QNECADYINVQKARG | 221 | Q5H9K5 | |
| NFGFELVIQYNENKQ | 1951 | Q15911 | |
| QYQLEEFKLCLEPQQ | 26 | Q86W25 | |
| EQFCINYCNEKLQQL | 396 | O94832 | |
| GLKTENCIENLEYFQ | 261 | Q13508 | |
| IQYFNNKVVCDLIEN | 436 | O00160 | |
| NGFEQFCINYCNEKL | 401 | Q8N1T3 | |
| EQFCINYANEKLQQQ | 451 | Q9ULV0 | |
| CEQYAKEQGAQERNA | 1326 | Q13402 | |
| KQIQVDLQDLGYETC | 1266 | Q5VU43 |